DR. M.D., PhD Associate Professor

Medical Specialist, AII - Cancer immunology Medical Specialist, CCA - Cancer Treatment and quality of life Medical Specialist, CCA - Cancer biology and immunology Medical Specialist, Pulmonary medicine

Specialization

Thoracic Oncology

Focus of research

Idris Bahce is a Thoracic Oncologist and Associate Professor of the Multidisciplinary Thoracic Oncology Research Group at Amsterdam UMC.

 

Background

Idris Bahce finished his medical degree (CUM LAUDE) at the University of Leuven in 2003. He finished his specialization as a pulmonologist in 2009 in Arnhem. During his PhD, at the Amsterdam UMC location VUmc, he investigated the potential of PET using radiolabeled targeting agents, i.e. TKI-PET using [11C]C-erlotinib and immune-PET using [89Zr]Zr-bevacizumab, directed against non-small cell lung cancer (NSCLC), to characterize tumors and determine their sensitivity to the given agents. For his research he received the Woldringprijs in 2018, the Dutch award for the best PhD research in the field of nuclear medicine issued by NVNG.

Research Interests

  • Resistance mechanisms of immunotherapy in NSCLC
  • Multimodality combination immunotherapies
  • PET imaging using radiolabeled drugs against lung cancer

 

ACTIVITIES

  • Member Theme leaders ‘Cancer Immunology’, Cancer Center Amsterdam (CCA) and Amsterdam institute for Infection and Immunity (AII)
  • Member Guidelines Commission (Richtlijnencommissie) NVALT, Dutch Guidelines on Non-small Cell Lung Cancer
  • Member Guidelines Commission (Richtlijnencommissie) NVALT, Dutch Guidelines on Lung Cancer Surgery Guidelines